Journal of thrombosis and haemostasis : JTH

publication venue for

Novel aspects of Kindlin-3 function in humans based on a new case of leukocyte adhesion deficiency III. 2012
Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. 2009
Novel ADAMTS-13 mutations in an adult with delayed onset thrombotic thrombocytopenic purpura. 2006
Onset of labor and use of analgesia in women using thromboprophylaxis with 2 doses of low-molecular-weight heparin: insights from the Highlow study.. 21. 2022
Ischemic stroke with cancer: Hematologic and embolic biomarkers and clinical outcomes.. 20. 2022
Diagnosis and management of severe congenital protein C deficiency (SCPCD): Communication from the SSC of the ISTH.. 20. 2022
Neonatal platelet transfusions: New evidence and the challenges of translating evidence-based recommendations into clinical practice.. 20. 2022
ISTH definition of pulmonary embolism-related death and classification of the cause of death in venous thromboembolism studies: Validation in an autopsy cohort.. 19. 2021
Tissue factor upregulation is associated with SARS-CoV-2 in the lungs of COVID-19 patients.. 19. 2021
Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis: Update of the guidelines for lupus anticoagulant detection and interpretation.. 18. 2020
Extreme thrombocytosis is associated with critical illness and young age, but not increased thrombotic risk, in hospitalized pediatric patients.. 18. 2020
Use of plasma-derived factor X concentrate in neonates and infants with congenital factor X deficiency.. 18. 2020
Comparison of real world and core laboratory lupus anticoagulant results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) clinical database and repository.. 17. 2019
Definition of bleeding events in studies evaluating prophylactic antithrombotic therapy in pregnant women: A systematic review and a proposal from the ISTH SSC.. 17. 2019
The risk of major bleeding in patients with suspected heparin-induced thrombocytopenia.. 17. 2019
McMaster RARE-Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome.. 16. 2018
Reduction of annexin A5 anticoagulant ratio identifies antiphospholipid antibody-positive patients with adverse clinical outcomes.. 15. 2017
Associations of coagulation factors IX and XI levels with incident coronary heart disease and ischemic stroke: the REGARDS study.. 15. 2017
Hemostasis biomarkers and risk of sepsis: the REGARDS cohort.. 14. 2016
Clinical adherence to thrombophilia screening guidelines at a major tertiary care hospital.. 14. 2016
Changes in the amino acid sequence of the recombinant human factor VIIa analog, vatreptacog alfa, are associated with clinical immunogenicity.. 13. 2015
Multicenter randomized controlled trial on Duration of Therapy for Thrombosis in Children and Young Adults (the Kids-DOTT trial): pilot/feasibility phase findings.. 13. 2015
Recurrent venous thromboembolism in anticoagulated patients with cancer: management and short-term prognosis.. 13. 2015
β-1 tubulin R307H SNP alters microtubule dynamics and affects severity of a hereditary thrombocytopenia.. 13. 2015
Stalled cerebral capillary blood flow in mouse models of essential thrombocythemia and polycythemia vera revealed by in vivo two-photon imaging.. 12. 2014
Recombinant factor VIIa analog in the management of hemophilia with inhibitors: results from a multicenter, randomized, controlled trial of vatreptacog alfa.. 12. 2014
Decreased plasma cytokines are associated with low platelet counts in aplastic anemia and immune thrombocytopenic purpura.. 10. 2012
Differences in platelet function in patients with acute myeloid leukemia and myelodysplasia compared to equally thrombocytopenic patients with immune thrombocytopenia.. 9. 2011
Extracellular histones increase plasma thrombin generation by impairing thrombomodulin-dependent protein C activation.. 9. 2011
Innate immunity and coagulation.. 9 Suppl 1. 2011
The HIT Expert Probability (HEP) Score: a novel pre-test probability model for heparin-induced thrombocytopenia based on broad expert opinion.. 8. 2010
Risk factors for developing a new venous thromboembolism in ambulatory patients with non-hematologic malignancies and impact on survival for gastroesophageal malignancies.. 8. 2010
Pharmacokinetics and safety of fibrinogen concentrate.. 7. 2009
The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: an international multicenter study.. 7. 2009
Endogenous activated protein C signaling is critical to protection of mice from lipopolysaccaride-induced septic shock.. 7. 2009
Power Doppler sonography in the diagnosis of hemophilic synovitis--a promising tool.. 6. 2008
Covalent regulation of ULVWF string formation and elongation on endothelial cells under flow conditions.. 6. 2008
Persistent platelet activation in patients with type 2 diabetes treated with low doses of aspirin.. 5. 2007
Reticulated platelets and uninhibited COX-1 and COX-2 decrease the antiplatelet effects of aspirin.. 5. 2007
First experience with direct, selective factor Xa inhibition in patients with non-ST-elevation acute coronary syndromes: results of the XaNADU-ACS Trial.. 3. 2005
Initial experience with factor-Xa inhibition in percutaneous coronary intervention: the XaNADU-PCI Pilot.. 2. 2004
Rare Bleeding Disorder Registry: deficiencies of factors II, V, VII, X, XIII, fibrinogen and dysfibrinogenemias.. 2. 2004
Platelet FcgammaRIIA His131Arg polymorphism and platelet function: antibodies to platelet-bound fibrinogen induce platelet activation.. 1. 2003
Corrigendum to Diagnosis and management of severe congenital protein C deficiency (SCPCD): Communication from the SSC of the ISTH [J Thromb Haemost. 2022 Jul;20(7):1735-1743].. 21. 2023
The use of LMWH in pregnancies at risk: new evidence or perception? 2005
False-positive tests for heparin-induced thrombocytopenia in patients with antiphospholipid syndrome and systemic lupus erythematosus: a rebuttal. 2010
The international immune tolerance study: a multicenter prospective randomized trial in progress. 2006
Resistance to annexin A5 binding and anticoagulant activity in plasmas from patients with the antiphospholipid syndrome but not with syphilis. 2006
Adverse effects of estrogen therapy in a subset of women with ITP. 2004
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). 2006
Anticoagulant interventions in hospitalized patients with COVID-19: A scoping review of randomized controlled trials and call for international collaboration. 2020
Recurrent thrombosis in patients with antiphospholipid antibodies and an initial venous or arterial thromboembolic event: A systematic review and meta-analysis. 2020
Megakaryocytes, malignancy and bone marrow vascular niches. 2012
Diagnosis and management of the fetus and neonate with alloimmune thrombocytopenia. 2009
Immune tolerance therapy for factor VIII inhibitors: moving from empiricism to an evidence-based approach. 2007
Heterologous cell-cell interactions: thromboregulation, cerebroprotection and cardioprotection by CD39 (NTPDase-1). 2003

VIVO Weill Cornell Medical College

Journal of thrombosis and haemostasis : JTH Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)